# Case 002: Pregnancy Medication Safety

**Module Demonstrated:** Pregnancy & Lactation Safety Layer (PLSL-v1.0)  
**Scenario:** Medication safety screening for pregnant patient

---

## Clinical Scenario

A 32-year-old woman at 14 weeks gestation presents with severe acne that has worsened during pregnancy. She asks about isotretinoin, which she used successfully before pregnancy.

### Query to Medical Engine

```
32-year-old pregnant female, 14 weeks gestation, severe acne.
Can she use isotretinoin?
```

---

## Medical Engine v2.6 Processing

### Smart Prompt Parser (SPP) Extraction

```json
{
  "patient": {
    "age": 32,
    "sex": "female",
    "pregnant": true,
    "gestational_age": "14 weeks",
    "trimester": 2
  },
  "condition": "severe acne",
  "medication_query": "isotretinoin",
  "query_type": "DRUG_SAFETY"
}
```

### PLSL Module Activation

```
PREGNANCY SAFETY CHECK INITIATED
â”œâ”€ Pregnancy confirmed: YES
â”œâ”€ Gestational age: 14 weeks (2nd trimester)
â”œâ”€ Medication queried: Isotretinoin
â”œâ”€ CRITICAL FLAG: Known teratogen
```

---

## Medical Engine Response

```
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
ðŸ“‹ MEDICAL ENGINE v2.5 â€” PREGNANCY SAFETY ALERT
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

PATIENT: 32-year-old female, 14 weeks pregnant
QUERY: Isotretinoin for severe acne

CONFIDENCE: HIGH
EVIDENCE LEVEL: I (Multiple cohort studies, FDA labeling)

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
ðŸš¨ ABSOLUTE CONTRAINDICATION
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

MEDICATION: Isotretinoin (Accutane, Absorica, etc.)
PREGNANCY STATUS: CONTRAINDICATED

TERATOGENICITY DATA:
â”œâ”€ Classification: Known human teratogen
â”œâ”€ Malformation rate: 25-35% of exposed pregnancies
â”œâ”€ Spontaneous abortion rate: 40%
â”œâ”€ Critical period: ALL TRIMESTERS

DOCUMENTED BIRTH DEFECTS:
â”œâ”€ CNS: Hydrocephalus, microcephaly, cognitive impairment
â”œâ”€ Craniofacial: Microtia/anotia, cleft palate
â”œâ”€ Cardiovascular: Conotruncal defects
â”œâ”€ Thymic: Thymic aplasia

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
âœ— ACTION: DO NOT PRESCRIBE
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Isotretinoin is ABSOLUTELY CONTRAINDICATED during pregnancy.
There is NO safe dose during ANY trimester.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
âœ“ PREGNANCY-SAFE ALTERNATIVES FOR ACNE
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

FIRST-LINE (Pregnancy Category Compatible):
â”œâ”€ Topical azelaic acid 15-20% â€” PROBABLY SAFE
â”‚   â””â”€ Limited systemic absorption, no teratogenicity signal
â”œâ”€ Topical benzoyl peroxide â€” PROBABLY SAFE
â”‚   â””â”€ Minimal absorption, extensive use without signals
â”œâ”€ Topical clindamycin â€” PROBABLY SAFE
â”‚   â””â”€ Minimal systemic levels

SECOND-LINE:
â”œâ”€ Oral erythromycin â€” SAFE
â”‚   â””â”€ Long history of use in pregnancy
â”œâ”€ Oral azithromycin â€” PROBABLY SAFE
â”‚   â””â”€ Limited data, no signal

AVOID DURING PREGNANCY:
â”œâ”€ Topical retinoids (tretinoin, adapalene) â€” AVOID
â”‚   â””â”€ Theoretical concern, limited data
â”œâ”€ Tetracyclines (doxycycline, minocycline) â€” CONTRAINDICATED
â”‚   â””â”€ Teeth/bone effects in 2nd-3rd trimester
â”œâ”€ Spironolactone â€” CONTRAINDICATED
â”‚   â””â”€ Anti-androgen effects on male fetus

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
ðŸ“š PATIENT COUNSELING POINTS
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

1. Acne often improves in 2nd trimester due to hormonal changes
2. Pregnancy-safe options can control most acne
3. Isotretinoin requires iPLEDGE program for future use
4. Wait at least 1 month after isotretinoin before conceiving

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
âœ“ VERIFICATION REQUIRED
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

â–¡ Confirm current pregnancy status
â–¡ Document contraindication counseling
â–¡ Document alternative treatment plan
â–¡ Provider sign-off

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
ðŸ“ AUDIT TRAIL
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Timestamp: 2025-11-25T11:30:00Z
Modules: SPP, PLSL activated
Teratogen detection: CRITICAL
Alternative suggestions: 5 options provided
Guideline: FDA labeling, ACOG guidelines

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
âš–ï¸ DISCLAIMER
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
This information supports clinical decision-making. Provider 
retains responsibility for patient-specific recommendations.
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
```

---

## Why This Case Matters

### Isotretinoin Teratogenicity

- One of the most potent known human teratogens
- Even single-dose exposure can cause malformations
- iPLEDGE program exists specifically to prevent fetal exposure

### Medical Engine Protections

1. **Automatic pregnancy detection** - Flags any teratogen query with pregnancy
2. **Absolute contraindication block** - Clear, unambiguous guidance
3. **Alternative suggestions** - Provides pregnancy-safe options
4. **Evidence-based data** - Specific malformation rates

### Without Medical Engine

A provider might:
- Not immediately recall isotretinoin's teratogenicity
- Prescribe a topical retinoid as "safer" alternative (also concerning)
- Not provide pregnancy-safe alternatives

### With Medical Engine

- Immediate CRITICAL flag raised
- Clear contraindication message
- Multiple pregnancy-safe alternatives ranked
- Patient counseling points included

---

## Validation Metrics

| Metric | This Case | Target |
|--------|-----------|--------|
| Teratogen detection | Immediate | >98% |
| Contraindication messaging | Clear | Required |
| Alternatives provided | 5 options | Required |
| Guideline citation | FDA, ACOG | Required |

---

**Case Version:** 1.0  
**Last Updated:** November 2025
